首页> 外文会议>Society for biomaterials annual meeting and exposition >Encapsulation of antigen in chitosan particles enhances activation and antigen specific response by antigen presenting cells
【24h】

Encapsulation of antigen in chitosan particles enhances activation and antigen specific response by antigen presenting cells

机译:在壳聚糖颗粒中抗原的封装增强了通过抗原呈递细胞的活化和抗原特异性响应

获取原文

摘要

In this study, we explored the effects of antigen-encapsulated chitosan particles on APC uptake and function. Our results indicate that encapsulation of subunit antigen in chitosan particles enhances antigen delivery and subsequent activation of APCs. In all measures of APC activation and presentation, AgCPs outperformed soluble antigen. The ability of BMDC's pulsed with AgCPs to present both MHC I and MHC II epitopes is particularly encouraging. Modification of chitosan or incorporation of additional immune response modifiers may permit the direction of a vaccine response toward either humoral or cell-mediated immunity. Taken together, our results indicate that AgCPs are a promising vaccine delivery platform deserving of continued exploration. Future studies will evaluate the in vivo immune response to chitosan particle-based antigen delivery systems.
机译:在这项研究中,我们探讨了抗原包封的壳聚糖颗粒对APC吸收和功能的影响。我们的研究结果表明,壳聚糖颗粒中亚基抗原的封装增强了抗原递送和随后的APC活化。在APC活化和呈列的所有措施中,AGCP优于可溶性抗原。 BMDC脉冲的能力与AGCPS呈现出MHC I和MHC II表位尤为令人鼓舞。壳聚糖的改性或掺入额外的免疫反应改性剂可以允许疫苗响应对体液或细胞介导的免疫的方向。我们的结果表明,AGCP是一个值得持续勘探的有前途的疫苗交付平台。未来的研究将评估对壳聚糖颗粒基抗原输送系统的体内免疫应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号